Alcon acquires right to market DUREZOL ophthalmic corticosteroid in U.

Alcon acquires right to market DUREZOL ophthalmic corticosteroid in U.S.S. Food and Medication Administration in 2008. Durezol’s unique capacity to effectively and quickly treat both inflammation and discomfort following ocular surgery helps it be a great match for Alcon’s leading product portfolio. .He has termed it cell resonance. So all the premier research labs products are guided by the theory of cell resonance. Different products have different frequencies because they are targeted for different body parts of the body. Pristine source The lab sources nutritional elements only from pristine and live sources. This is to ensure that unwanted chemical substances and hormones usually do not make method into the premier study labs supplements and hinder bodily functions. Strict testing All the elements undergo rigorous testing to find that no chemical substance or other unwanted materials is entering the creation process. They do all kinds of testing like 4-polarity resonance testing etc.